Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Smoothened agonist.
GSK-3β inhibitor.
Thiol derivative, antioxidant.
K+ channel blocker, catecholamine release stimu...
Diterpene found in coffee beans.
δ2OR antagonist.
JAK2 inhibitor.
Inhibitor of PI3K.
Fibrate; PPARα agonist, enoyl-CoA reductase in...
AMPK activator, L-type Ca2+ channel and NMDA, h...
Furanolactone found in citrus fruits.
β-lactam; penicillin binding protein inhibitor...
Thiazolidine macrolide found in the Red Sea spo...
Fluoroquinolone; bacterial DNA gyrase inhibitor...
PDE3 inhibitor.
Endogenous peptide, produced by activation of P...
FXR agonist.
Alkylphenol found in Ginkgo; HIV protease inhib...
EGFR (WT, T790M) inhibitor.
Inhibitor of CDK.